Yahoo Web Search

Search results

    • Vaxart Provides Business Update

      Morningstar· 4 days ago

      Vaxart anticipates that net proceeds from the recent $40 million offering, expected fees and reimbursements under its Project NextGen award of up to $453 million, combined with its existing ...

    • Gateway - Quartz

      Quartz· 2 days ago

      The U.S. government is close to finalizing a deal to fund a late-stage trial of Moderna’s mRNA H5N1 bird flu vaccine, as the virus continues to spread rapidly among poultry and cattle and has ...